ClinConnect ClinConnect Logo
Search / Trial NCT04900493

The Rett Syndrome Global Registry

Launched by RETT SYNDROME RESEARCH TRUST · May 19, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Mecp2 Registry Rsrt

ClinConnect Summary

The Rett Syndrome Global Registry is a project that aims to gather important information about caring for individuals with Rett syndrome, a rare genetic disorder. This registry is entirely online, allowing caregivers from all over the world to share their experiences and insights. Caregivers can track their loved one's symptoms and care strategies over time, and they have the option to combine medical records for easier access. Researchers can use this collected information to better understand Rett syndrome and improve future treatments.

To participate in this registry, caregivers must be able to provide electronic consent, and they must be caring for someone diagnosed with Rett syndrome or who has a specific genetic mutation called MECP2. The registry is open to individuals of all ages, whether they are currently living or have passed away. This is a great opportunity for caregivers to contribute to research that could lead to better care and clinical trials for Rett syndrome in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Parent/caregiver must be willing and able to provide written informed consent electronically prior to entering data into the registry.
  • 2. Rett individuals of any age, living or deceased, must have a diagnosis of Rett syndrome and/or have a mutation in MECP2.
  • Exclusion Criteria:
  • 1. Individuals who have a genetic mutation that is inconsistent with Rett syndrome or who have a different disorder.
  • 2. Individuals with MECP2 Duplication Syndrome

About Rett Syndrome Research Trust

The Rett Syndrome Research Trust (RSRT) is a leading non-profit organization dedicated to accelerating research and advancing therapeutic strategies for Rett syndrome, a neurodevelopmental disorder primarily affecting females. Founded by a community of families and advocates, RSRT focuses on funding innovative scientific studies, fostering collaboration among researchers, and promoting awareness of the condition. Through strategic partnerships and a commitment to rigorous scientific inquiry, RSRT aims to drive breakthroughs that will ultimately lead to effective treatments and improve the quality of life for individuals affected by Rett syndrome.

Locations

Trumbull, Connecticut, United States

Patients applied

0 patients applied

Trial Officials

Jana von Hehn, PhD

Principal Investigator

Rett Syndrome Research Trust

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials